New CRISPR Tool Fixes CFTR Mutations in CF Patients’ Stem Cells, Study Finds
A new variation of the gene-editing technology CRISPR-Cas9 can correct mutations in the CFTR gene — the genetic cause of cystic fibrosis...
New Tool for Rapidly Analyzing CRISPR Edits Reveals Frequent Production of Unintended Edits
New method unmasks all DNA changes caused by CRISPR in two days vs two months WILMINGTON, DE — Amidst rising hopes for using CRISPR gene...
Vertex and Treating CF: High Hopes for Triple Combinations and Gene Therapy Possibilities
Editor’s note: This is third in a four-part series looking at Vertex Pharmaceuticals and its “all in for CF” approach. Here, we look at...
#ECRD2018 – Genome Editing Might Be ‘Cure’ for Rare Diseases But Ethical Guidelines Needed, Panel Sa
Should scientists have the right to edit the genes of future generations to eliminate hundreds, if not thousands, of potential rare...
